Singapore Nutritional Supplements Market Analysis Sample Report

Singapore
Nutritional
Supplements
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2023 – 2030F)

This report presents a strategic analysis of the Singapore Nutritional
Supplements Market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, main players, growth and demand drivers,
challenges & future outlook, etc. This is one of the most comprehensive
reports about the Singapore Nutritional Supplements Market, and offers
unmatched value, accuracy, and expert insights

3
A Sample Report on Singapore Nutritional Supplements Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Nutritional Supplements Overview 12-25
1.1. Overview
1.2. Singapore Overview
1.3. Economic Overview: Singapore
1.4. Nutritional Supplements Market in Singapore
1.5. Healthcare Services Market in Singapore
1.6. Healthcare Scenario in Singapore
1.7. Health Insurance Coverage: Singapore
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-33
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. Product
2.2.2. Type of service
2.2.3. Patient demographics
2.2.4. End-User
3. Market Dynamics 34-38
3.1. Market Growth Drivers
3.1.1. Singapore Nutritional Supplements Market Driver 1
3.2. Market Restraints
3.2.1. Singapore Nutritional Supplements Market Restraint 1

6
Table of Content
CONTENT PG. NO.
4. Competitive Landscape 39-49
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. GNC
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)

7
Table of Content
CONTENT PG. NO.
4.2.2. Eu Yan Sang International Singapore
4.2.2.2. Overview
4.2.3. Nutrilite
4.2.3.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.4. NutriFirst Singapore
4.2.4.2. Overview
4.2.5. Country life
4.2.5.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.6. Usana Singapore
4.2.6.1. Overview
4.2.7. Blackmores Singapore
4.2.7.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.8. Nature’s Farm Singapore
4.2.8.1. Overview
4.2.9. Swisse Singapore
4.2.9.1. Overview

11
Table of Content
CONTENT PG. NO.
4.2.10. Best World
4.2.10.2. Overview
5. Reimbursement Scenario 50-57
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Nutritional Supplements
6. Methodology & Scope 58-63

Singapore Nutritional Supplements Market Analysis
1. Nutritional Supplements Market Overview

13
1.1 Statistics at a Glance: The Burden of Nutritional Supplements in the World
Prevalence of Nutritional
Supplements ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Calcium and magnesium
are the most prevalent
minerals used in Nutritional
supplements globally
42%
of total market share was
captured by powder Segment
in Nutritional Supplements
market in the year 2022
Illustrative
24%
of total Nutritional
Supplements users use
energy boosting products
Multivitamins
were the most consumed
Nutritional Supplements in
2022.
78%
people aged 74+ use
supplements for brain health
$381.5 Bn
was the Nutritional
Supplements market size
in the year 2022.

14
1.1 Statistics at a Glance: Nutritional Supplements in the World (continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$7.6 Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$0.6Bn
Singapore Market
~$XX Mn Market
Illustrative

15
1.2 Singapore Overview
5.9 Mn
is the population of
Singapore, in 2022
42.2
is the median age
in Singapore, in
2022
466.78 Bn
is the Gross
Domestic Product
(GDP) in Singapore
in 2022
$1.49 K
per capita was the
amount of national
health expenditures in
2022
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest
Illustrative

16
1.3 Economic Overview: Singapore
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Singapore, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Singapore, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
48.84
Female
51.16
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Statistics at a Glance: Nutritional Supplements in Singapore
Prevalence of Nutritional Supplements
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Singapore
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
50%+
share of Singapore’s
health supplement
industry is held by
GNC
11.2 % and 6.4%
are respectively the shares of
dietary supplements of GNC
and Nutrilite in Singapore
17.5%
of total sales of vitamin’s and
protein supplements in
Singapore happened through
online mode in 2021
$ 456.9 Mn
is the average sales value
of nutritional supplements
in Singapore in year 2022
88%
of Singaporeans prefer
global brands of
nutritional supplements
over local options
139
list of products notified as
health supplements and
traditional medicines by
Health science authority of
Singapore has been
published in June 2023
Illustrative

18
1.5 Healthcare Services Market in Singapore
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Singapore Healthcare Services Market Forecast, 2022-2030 (in $Mn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Healthcare Services market in Singapore, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Singapore
Nutritional Supplements Treatment Process: The process of developing a cancer drug is complex and involves many stages, from preclinical
research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative

20
1.6 Healthcare Scenario in Singapore: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative

21
1.7 Health Insurance Coverage: Singapore
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
58,541 60,226 0.5
58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

22
1.8 Budget of Singapore Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Public
Insurance
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
$458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926
As % Of GDP
3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Public Insurance spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

23
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

24
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Partnership -- 2022
▪ Pharmactive and Nutraconnect came in partnership in 2022.
▪ Pharmactive will provide its botanical extract ingredients
▪ Nutraconnect will function as a growth engine for the region in
Asia pacific
Acquisition
--
2022
▪ Everstone Capital, the private equity arm of Everstone Group, has
acquired a controlling stake in Softgel Healthcare (SHPL),a
neutraceutical company in Singapore.
▪ The Singapore-headquartered firm Softgel healthcare said with
the acquisition it will aim to scale, diversify, and globally recognize
contract research, development, and manufacturing organization
Latest Deals In Singapore
Illustrative

25
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Merger $270 Mn 2023
▪ Wellous a nutraceutical company with prevalence in Singapore
came into merger deal with kairous acquisition corporation
limited.
▪ Becoming a public company has always been a part of wellous
business strategy, and the merger with Kairous will provide them
access to the US markets and potential capacity in accelerating
the growth.
Latest Deals In Singapore
Illustrative

2. Market Size and Forecasting

27
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
2.1 Market Size and Forecasts (Excel and Methodology)
Singapore Nutritional Supplements Market Forecast, 2022-2030 (in
$Bn)
final report
understanding of the overall Nutritional
Supplements market in Singapore,
which includes the market size, current
trends and other details related to the
topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Singapore Patient Size
(Bn)
0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Singapore Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Singapore Market Size
(Bn $)
61 74 84 87 91 95 99 106
Illustrative

28
▪ In this section you will get an understanding of the segmentations which will cover the Singapore Nutritional Supplements Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
By Delivery
Channel
Chemists/
Pharmacists
Direct to consumer
sales
E- Commerce
By Consumer
Group
Infants
Children
Adults
Pregnant
Geriatric
Product
Sports Nutrition
Fat burners
Dietary supplements
Functional foods
By Formulation
Tablets
Capsules
Powder
Soft gels
Liquid
Others
2.2 Snapshot of Nutritional Supplements Market Segmentation

29
Singapore Nutritional Supplements Market Share, By Product
(2022)
Sports
nutrition
Fat Burners
Dietary
supplements
Functional Foods
▪ In Product segment Dietary
supplements is a significant component
of the overall Nutritional Supplements
market in Singapore
▪ It has the maximum market share in
Singapore Nutritional Supplements
Market with approximately xx%
final report
2.2.1 Market Segmentation: By Product
Illustrative

30
Singapore Nutritional Supplements Market Share, By Formulation
(2022)
▪ In Formulation segment Powder is a
significant component of the overall
Nutritional Supplements market in
Singapore.
final report
2.2.2 Market Segmentation: By Applications
Illustrative
Tablets
Capsules
Powder
Soft gels
Liquid
Others

31
Singapore Nutritional Supplements Market Share, By consumer
group (2022)
▪ In consumer group segment Adults and
geriatric are a significant component of
the overall Nutritional Supplements
market in Singapore.
final report
2.2.3 Market Segmentation: By consumer group
Illustrative
Infants
Children
Adults
Pregnant
Geriatric

3. Market Dynamics

33
3.1 Market growth drivers
▪ Increase in geriatric population in Singapore with people suffering from
various ailments and disorders requiring Nutritional Supplements. It is
projected people aged 60 years and over surpassing 15% of the working
population in 2030
▪ This is driving the demand for Nutritional Supplements treatments such
as bone health supplements and cognitive health products and creating
opportunities for growth in the Nutritional Supplements market.
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
Increase of mean age in Singapore
Illustrative
3.1.1 Growing aging population with above 34% of working population aged 65 years and above by 2035

34
▪ Disposable income is growing at a high rate in Singapore
due to rapidly accelerating employee compensation and
GST voucher scheme’s cash payouts
▪ A report from Department of Statistics of Singapore states
that personal disposable incomes in Q3 of year 2022 has
grown by 9.8%
▪ This increase in disposable incomes causes overspending
by people of Singapore and leads to increased spending on
nutritional supplements.
Illustrative
3.1.2 Growth in disposable income in Singapore at a high rate
3.1 Market growth drivers (continued)

35
▪ Health Sciences Authority( HSA) of Singapore has set up
guidelines to ensure the safety and quality of Nutritional
supplements by setting up toxicity limits of various
substances used.
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
Regulatory Body Guideline Permissible Limits
Heath Sciences
Authority (HSA)
Substances not
allowed
Xx
Toxic heavy metal
Limits
Xx ppm
Microbial Limits Xx CFU
Vitamin and mineral
limits
Xx mg
Illustrative
3.1.3 Government initiatives to support Nutritional Supplements in Singapore
3.1 Market growth drivers (continued)

36
3.2 Market restraints
3.2.1 Limited domestic
production of
Nutritional supplements
in Singapore
▪ Singapore has limited domestic
production capabilities for
nutritional supplements. Most
products are imported, which can
result in higher costs due to
import duties, transportation
expenses
▪ Only 12% of Singaporeans use
domestically produced nutritional
supplements
3.2.2 Fragmented Nutritional
Supplements market
structure in Singapore
▪ Market structure of Nutritional
Supplements in Singapore is
fragmented which makes
difficulty in coordination and
establishing standardized
guidelines
▪ In this type of market there is
limited barrier to entry and lack
of market dominance by a single
firm
3.2.3 Limited awareness about
Nutritional Supplements in
Singapore
▪ There is Limited awareness
about Nutritional Supplements in
Singapore
▪ Increasing public knowledge
about the role of supplements in
addressing specific nutritional
needs and supporting overall
health can be done
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

38
4.1 Major Market Share
XX
Other
▪ Some of the top companies in Singapore
Nutritional Supplements Market based on
revenue and market share include
interest
Revenue of Major Players in Singapore Nutritional Supplements
Market ($ Mn)
Illustrative

39
4.2 Key Company Profile
Key Notes
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
Illustrative
1 GNC
3 Nutrilite
5 Country life
7 Blackmores Singapore
9 Swisse Singapore
2 Eu Yan Sang
4 NutriFirst Singapore
6 Usana Singapore
8 Nature’s Farm Singapore
Best world
10

40
4.2.1 GNC
Founded in: 1935
HQ: Pittsburgh, Pennsylvania
Type: Private
Website: www.gnc.com
▪ GNC is one of the leading nutritional supplements supplier in
Singapore and operates in many segments.
▪ It has many centers in the country and operates through online
mode as well.
▪ It has global presence in more than 50 countries.
Solutions offered by GNC
Singapore
➢ Nutritional Supplements
➢ Specialty Nutrition
➢ Child Nutrition
➢ Diet and weight management
Recent Activity / Press Coverage
GNC and CTRL announce new partnership and exclusive launch of product line for gamers
GNC live well foundation raises $100,000 to support American diabetes association
GNC unveiled wellness tracking feature in mobile app as part of company’s health and wellness capabilities
Illustrative

41
4.2.1 GNC
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

42
4.2.1 GNC
Company Type
Amount /
Shares
Year Key Pointers
Partnership $Xx Mn June 2023
▪ Partnership is aimed for exclusive launch of product line for
gamers those looking to embrace healthier dietary and nutrition
habits.
▪ Expanding GNC's gaming assortment with these exclusive CTRL
meal replacement and functional food products is the main goal
of this partnership.
Latest Deals - Mergers and Acquisitions
Illustrative

43
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
4.2.1 GNC
Revenues ($Bn), 2020-2030
▪ GNC is a one of the leading Nutritional
Supplements company in Singapore
▪ As of December 31, 2022, the company
had a market share of Xx % in the
Nutritional Supplements industry in
Singapore
▪ GNC Singapore reported a total revenue of
RM Xx billion for the financial year ended
November 30, 2022, representing a 11%
increase from the previous year
▪ Company's net profit after tax for the same
period was RM Xx Mn, a Xx increase from
the previous year
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

44
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

45
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

46
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

47
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
▪ Please be aware that this sample report is
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

49
5.1 Reimbursement Regulation in Singapore
The reimbursement scenario in Singapore nutritional supplement market is
complex and can vary depending on the specific treatment, setting of care, and
insurance coverage. Here are some key points to consider:
▪ Public Insurance:
o Medicare is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Medicare covers many cancer treatments, including chemotherapy,
radiation therapy, and some immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
o Medicaid is a joint federal-state program that provides health insurance
for people with low incomes
o Medicaid coverage for cancer treatments can vary by state, and may be
subject to limits on the amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Population
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

50
5.1 Reimbursement Regulation in Singapore (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover
certain preventive services, including cancer screenings, without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as cancer
▪ Reimbursement for New Treatments:
o Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs
often require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

51
5.1 Reimbursement Regulation in Singapore (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

52
5.2 Reimbursement Process for Nutritional Supplements
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Healthcare Services
and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Healthcare Services
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Singapore Nutritional Supplements Market Analysis Sample Report

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Singapore Nutritional Supplements Market Analysis Sample Report

Similar to Singapore Nutritional Supplements Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Singapore Nutritional Supplements Market Analysis Sample Report